Cytosorbents shares
WebFeb 15, 2024 · Cytosorbents Corporation Common ... "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and ... WebView the latest Cytosorbents Corp. (CTSO) stock price, news, historical charts, analyst ratings and financial information from WSJ. CTSO Cytosorbents Corp. Stock Price & …
Cytosorbents shares
Did you know?
WebJul 6, 2024 · CytoSorbents Corporation (NASDAQ:CTSO) receives full FDA approval to conduct the STAR-T trial in the U.S. to support regulatory clearance of DrugSorb Antithrombotic Removal (ATR) system for ... WebA. The Company and the Investor are parties to a Purchase Agreement dated as of May 5, 2010 (the “Purchase Agreement”), pursuant to which, among other things, the Company has the right to sell to the Investor, at its sole discretion, up to $6,000,000 of the Company’s common stock, par value $0.001 per share (“Common Stock”), upon the terms and …
WebJul 22, 2024 · The Company has also granted the underwriters a 30-day option to purchase up to 789,473 additional shares of common stock at the public offering price less the … WebJan 26, 2024 · Cytosorbents is a smaller company with a market capitalization of US$415m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that...
WebApr 13, 2024 · Cytosorbents is a smaller company with a market capitalization of US$389m, so it may still be flying under the radar of many institutional investors. Taking a look at our data on the ownership... WebGet the latest Cytosorbents Corp (CTSO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …
WebCytoSorbents aims to be in the elite company of fast growing medical device companies, with rapid growth, industry leading product gross margins in excess of 80%, and GAAP …
WebApr 12, 2024 · Cytosorbents issued an update on its fourth quarter 2024 earnings guidance on Tuesday, January, 31st. The company provided earnings per share guidance of for … portland naWebNov 4, 2024 · CytoSorbents (CTSO) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.15 per share a year ago. These... portland nannies portland maineWebWarrants: 50% Warrant coverage as follows: The Company will issue the Creditor five-year warrants (the “Warrants”) to purchase that number of shares of Common Stock equal to the quotient obtained by dividing (x) 50% of the Principal, by (y) $0.10, with the resulting number of shares having an exercise price equal to $0.125 per share of Common Stock. optima scopes reviewsWebMar 10, 2024 · Cytosorbents Corp's market capitalization is $163.85 M by 43.64 M shares outstanding. Is Cytosorbents stock a Buy, Sell or Hold? Cytosorbents stock has … optima screenWebMar 28, 2024 · Cytosorbents Co. ( NASDAQ:CTSO – Get Rating) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.13 and traded as high as $3.38.... optima scales op-900bWebCytoSorb ® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed … optima screensWebCytosorbents shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion … portland museum of art biennial